Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  ACS Chemical Neuroscience

• Publication date

  2014-07-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/cn5000524PMID 25029033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats

  2014cited by this paper
• Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.

  2014cited by this paper
• Role of TRPV1 in susceptibility to PTZ-induced seizure following repeated hyperthermia challenges in neonatal mice.

  2014cited by this paper
• Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats.

  2013cited by this paper
• Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism

  2013cited by this paper
• Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression

  2013cited by this paper
• Astrocytes express functional TRPV2 ion channels.

  2013cited by this paper
• GABA and glutamate are not colocalized in mossy fiber terminals of developing rodent hippocampus.

  2012cited by this paper
• Increased Expression of TRPV 1 in the Cortex and Hippocampus from Patients with Mesial Temporal Lobe Epilepsy

  2012cited by this paper
• Phytocannabinoids as novel therapeutic agents in CNS disorders.

  2012cited by this paper
• Cannabidivarin is anticonvulsant in mouse and rat

  2012cited by this paper
• Increased Expression of TRPV1 in the Cortex and Hippocampus from Patients with Mesial Temporal Lobe Epilepsy

  2012cited by this paper
• Expression and distribution of TRPV2 in rat brain.

  2012cited by this paper
• The functions of TRPA1 and TRPV1: moving away from sensory nerves

  2012cited by this paper
• Disease-related changes in TRPV1 expression and its implications for drug development.

  2011cited by this paper
• Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

  2011cited by this paper
• Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.

  2011cited by this paper
• Trpv1 Reporter Mice Reveal Highly Restricted Brain Distribution and Functional Expression in Arteriolar Smooth Muscle Cells

  2011cited by this paper
• Development of multi-electrode array screening for anticonvulsants in acute rat brain slices.

  2010cited by this paper
• Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

  2010cited by this paper
• Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.

  2010cited by this paper
• Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

  2009cited by this paper
• TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons

  2008cited by this paper
• Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8

  2008cited by this paper
• Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol*

  2008cited by this paper
• Increased sensitivity of desensitized TRPV1 by PMA occurs through PKC&egr;‐mediated phosphorylation at S800

  2006cited by this paper
• TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists

  2006cited by this paper
• Adult epilepsy.

  2006cited by this paper
• Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.

  2006cited by this paper
• Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.

  2005cited by this paper
• Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia

  2005cited by this paper
• Frequent coexpression of the vesicular glutamate transporter 1 and 2 genes, as well as coexpression with genes for choline acetyltransferase or glutamic acid decarboxylase in neurons of rat brain

  2005cited by this paper
• The epidemiology of epilepsy in Europe – a systematic review

  2005cited by this paper
• Biochemical pharmacology of the vanilloid receptor TRPV1

  2004cited by this paper
• Biochemical pharmacology of the vanilloid receptor TRPV1. An update.

  2004cited by this paper
• Vanilloid (capsaicin) receptors in health and disease.

  2002cited by this paper
• An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

  2002cited by this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cited by this paper
• Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist.

  2001cited by this paper
• Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

  2000cited by this paper
• Vanilloid (Capsaicin) receptors and mechanisms.

  1999cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• Temporal lobe epilepsy

  1984cited by this paper
• Clinical Pharmacology: Advances and Applications Dovepress Neuronal Potassium Channel Openers in the Management of Epilepsy: Role and Potential of Retigabine

  year unknowncited by this paper

• Cannflavin B ameliorates behavioural and neuronal systems alterations in adolescent rats exposed to prenatal valproic acid.

  2026cites this paper
• Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation

  2025cites this paper
• UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy

  2025cites this paper
• Evaluation of Cannabidiol Oil’s Effects on Sedation, Behavioral Responses to Handling, and Nociceptive Thresholds in Healthy Cats

  2025cites this paper
• Entourage effects of nonpsychotropic cannabinoids on visceral sensitivity in experimental colitis.

  2025cites this paper
• Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model.

  2025cites this paper
• The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology

  2025cites this paper
• Innovations in Cannabis Delivery Systems: A Patent Review (2012-2024).

  2025cites this paper
• Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum

  2025cites this paper
• The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets.

  2025cites this paper
• Cannabidiol attenuates methamphetamine-induced oxidative neurotoxicity via regulating transient receptor potential vanilloid type 1.

  2025cites this paper
• Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders.

  2025cites this paper
• Dietary targeting of TRPM8 rewires macrophage immunometabolism reducing colitis severity

  2025cites this paper
• The Phenolic Signature of Psidium cattleianum Fruits and Leaves Modulates TRPV1 and TRPA1 Transient Receptor Potential Channels: A Metabolomics, In Vitro, and In Silico Study

  2025cites this paper
• Carvone derived cannabidiol enantiomers as novel anticonvulsants

  2025cites this paper
• CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

  2025cites this paper
• Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

  2025cites this paper
• Are Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review

  2025cites this paper
• Cannabidivarin mitigates motor and cognitive impairments in a female mouse model of Rett syndrome.

  2025cites this paper
• The Development and Therapeutic Potential of Classical and Next-Generation Cannabinoid Ligands.

  2025cites this paper
• Sex differences in the capacity of minor phytocannabinoids to attenuate nociceptive insults in HIV-1 Tat-expressing mice

  2025cites this paper
• Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease.

  2025cites this paper
• Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD

  2025cites this paper
• Utilization of Cannabidiol in Post-Organ-Transplant Care

  2025cites this paper
• Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1

  2025cites this paper
• Cannabis sativa L. Extract Increases COX-1, COX-2 and TNF-α in the Hippocampus of Rats with Neuropathic Pain

  2025cites this paper
• Cannabidiol ameliorates seizures and neuronal damage in ferric chloride-induced posttraumatic epilepsy by targeting TRPV1 channel.

  2025cites this paper
• THC, CBD and minor cannabinoid CBDV differently modulate hippocampal neurons firing.

  2025cites this paper
• Utilização de Canabidiol no tratamento de crianças com Transtorno do Espectro Autista

  2025cites this paper
• Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons

  2024cites this paper
• A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors

  2024cites this paper
• Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels.

  2024cites this paper
• A cautionary tale of paradox and false positives in cannabidiol research

  2024cites this paper
• Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential

  2024cites this paper
• Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder

  2024cites this paper
• Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review

  2024cites this paper
• A journey through cannabidiol in Parkinson's disease.

  2024cites this paper
• Phytocannabinoids in neuromodulation: from omics to epigenetics.

  2024cites this paper
• Endocannabinoid regulation of inward rectifier potassium (Kir) channels

  2024cites this paper
• TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates.

  2024cites this paper
• Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock‐in mice

  2024cites this paper
• Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

  2024cites this paper
• Exploring the Role of TRP Channels and Neurotrophic Factors in Epileptogenesis: Insights from Diverse Seizure Models

  2024cites this paper
• Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.

  2024cites this paper
• New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect.

  2024cites this paper
• An overview of major depression disorder: The endocannabinoid system as a potential target for therapy

  2024cites this paper
• Damsin and neoambrosin: Two sesquiterpene lactones with affinity and different activity for PPAR and TRPA1 receptors.

  2024cites this paper
• Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice

  2024cites this paper
• Cannabinoid treatment for the symptoms of autism spectrum disorder

  2024cites this paper
• A Review of Sturge–Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways

  2024cites this paper
• In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution

  2024cites this paper
• Research trends and frontier hotspots of TRPV1 based on bibliometric and visualization analyses

  2024cites this paper
• Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine

  2024cites this paper
• The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

  2024cites this paper
• Therapeutic potential of cannabidiol in depression.

  2024cites this paper
• Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report

  2024cites this paper
• Cannabinol modulates the endocannabinoid system and shows TRPV1‐mediated anti‐inflammatory properties in human keratinocytes

  2024cites this paper
• Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders

  2024cites this paper
• Cannabidiol: metabolism and clinical efficacy in epileptic patients

  2024cites this paper
• Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics

  2024cites this paper
• Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors.

  2024cites this paper
• Microglial TRPV1 in epilepsy: Is it druggable for new antiepileptic treatment?

  2023cites this paper
• Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies

  2023cites this paper
• EXPLORANDO O POTENCIAL TERAPÊUTICO DOS CANABINOIDES EM DOENÇAS NEUROLÓGICAS

  2023cites this paper
• Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

  2023cites this paper
• EGb 761 reduces Ca2+ influx and apoptosis after pentylenetetrazole treatment in a neuroblastoma cell line

  2023cites this paper
• Anti-inflammatory effects of oral cannabidiol in rat models

  2023cites this paper
• Effects of Cannabidiol (CBD) on the inflammatory response of patients with rheumatoid arthritis.

  2023cites this paper
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

  2023cites this paper
• CBD can be combined with additional cannabinoids for optimal seizure reduction and requires GPR55 for its anticonvulsant effects

  2023cites this paper
• Unravelling a novel role for Cannabidivarin in the modulation of subventricular zone postnatal neurogenesis

  2023cites this paper
• Research Progress on the Role of Cannabidiol in Neuropathic Pain

  2023cites this paper
• The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential.

  2023cites this paper
• Cannabidiol sensitizes TRPV2 channels to activation by 2-APB

  2023cites this paper
• Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine

  2023cites this paper
• Real-world evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex.

  2023cites this paper
• Acute cannabidiol treatment enhances social interaction in adult male mice

  2023cites this paper
• Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge

  2023cites this paper
• Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease

  2023influential citation
• Pathophysiological Roles of Transient Receptor Potential (Trp) Channels and Zinc Toxicity in Brain Disease

  2023cites this paper
• Cannabidiol sensitizes TRPV2 channels to activation by 2-APB

  2023cites this paper
• THC and CBD: Similarities and differences between siblings.

  2023cites this paper
• The Polypharmacological Effects of Cannabidiol

  2023cites this paper
• Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors.

  2023cites this paper
• Antihypertensive effects of CBD are mediated by altered inflammatory response: A sub-study of the HYPER-H21-4 trial

  2023cites this paper
• Capsaicin alleviates neuronal apoptosis and schizophrenia-like behavioral abnormalities induced by early life stress

  2023cites this paper
• Tolerability of long‐term cannabidiol supplementation to healthy adult dogs

  2023cites this paper
• Non-Intoxicating Cannabinoids in Visceral Pain

  2023influential citation
• Cannabis Pharmacogenomics: A Path to Personalized Medicine

  2023cites this paper
• Phytocannabinoids Reduce Seizures in Larval Zebrafish and Affect Endocannabinoid Gene Expression

  2023cites this paper
• Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models

  2023cites this paper
• Cannabinoid treatments in epilepsy and seizure disorders.

  2023cites this paper
• Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome

  2022cites this paper
• High-Throughput Quantitation of Cannabinoids by Liquid Chromatography Triple-Quadrupole Mass Spectrometry

  2022cites this paper
• Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence

  2022cites this paper
• Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

  2022cites this paper
• Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review

  2022cites this paper
• Regulation of transient receptor potential channels by traditional Chinese medicines and their active ingredients

  2022cites this paper
• TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling

  2022cites this paper
• A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model

  2022cites this paper